Information for Cancer Registrars

Data Submission Requirements

Reporting Guidelines

Questions & Answers

Software and Services

Training

Home > Registrars > SEER Inquiry System > View

SEER Inquiry System - View

Print Question

Question: 20100050
Status Final References Source 1: 2010 SEER Manual pgs: 3 Notes: Example 6 Source 2: 2010 SEER Manual pgs: 4 Notes: Example 3 Question Reportability--Colon: Would a carcinoid tumor, NOS, of the appendix with perineural or angiolymphatic invasion be reportable if there is no mention of malignancy in the pathology report? Discussion Answer Carcinoids of the appendix are reportable when they meet any of the following conditions: The pathologist designates the carcinoid as malignant. Regional lymph nodes are positive for MALIGNANT carcinoid (not reportable if lymph nodes are reported to be involved with benign carcinoid disease). There are discontinuous metastatic implants or involvement. Note that the implants/involvement must be designated as malignant. Many benign tumors will spawn implants that are also benign. If implants are benign, this is not a reportable tumor. Neuroendocrine carcinoma is an NOS term that includes carcinoid tumors. The reportability requirements for CoC, the National Program of Cancer Registries (NPCR) CDC, and SEER National Cancer Institute have not changed. Carcinoids of the appendix are only reportable when they meet the criteria listed above. The MPH rules are currently under revision and the implementation date is 2014. This issue will be discussed by the GI specialty physicians, the ICD-O-3 editors and the MPH committee. Any change in reportability will be published in those rules and implemented in 2012. In the meantime, follow the reportability rules as published by the organizations to which you report cases. Note: The answers for SINQ questions with 2010 ID numbers were written using the 2010 Heme & Lymph Manual & DB. The instructions for using the 2010 Hematopoietic Database were written for the version of the software in use as of 5/24/2011. The user interface of the web-based 2010 Hematopoietic Database available from the SEER website varies slightly from the 5/24/2011 version in that the web-based version provides all the disease information in one scrollable window. For cases diagnosed 2010-2011, access the 2010 Hematopoietic Database at http://seer.cancer.gov/tools/heme/. Click on Hematopoietic Project. Click on Hematopoietic and Lymphoid Database. For 2010-2011 diagnoses, click on the "use the 2010 database" label in the upper right corner of the screen. The 2010 Hematopoietic Coding Manual (PDF) button will appear to indicate the correct version of the program is available now for query. History Last Updated 07/02/2012 Date Finalized

Question: 20100050

Status
Final

References
Source 1: 2010 SEER Manual
pgs: 3
Notes: Example 6
Source 2: 2010 SEER Manual
pgs: 4
Notes: Example 3

Question
Reportability--Colon: Would a carcinoid tumor, NOS, of the appendix with perineural or angiolymphatic invasion be reportable if there is no mention of malignancy in the pathology report?

Discussion

Answer
Carcinoids of the appendix are reportable when they meet any of the following conditions:

The pathologist designates the carcinoid as malignant.
Regional lymph nodes are positive for MALIGNANT carcinoid (not reportable if lymph nodes are reported to be involved with benign carcinoid disease).
There are discontinuous metastatic implants or involvement.

Note that the implants/involvement must be designated as malignant. Many benign tumors will spawn implants that are also benign. If implants are benign, this is not a reportable tumor.

Neuroendocrine carcinoma is an NOS term that includes carcinoid tumors. The reportability requirements for CoC, the National Program of Cancer Registries (NPCR) CDC, and SEER National Cancer Institute have not changed. Carcinoids of the appendix are only reportable when they meet the criteria listed above.

The MPH rules are currently under revision and the implementation date is 2014. This issue will be discussed by the GI specialty physicians, the ICD-O-3 editors and the MPH committee. Any change in reportability will be published in those rules and implemented in 2012. In the meantime, follow the reportability rules as published by the organizations to which you report cases.

Note: The answers for SINQ questions with 2010 ID numbers were written using the 2010 Heme & Lymph Manual & DB. The instructions for using the 2010 Hematopoietic Database were written for the version of the software in use as of 5/24/2011. The user interface of the web-based 2010 Hematopoietic Database available from the SEER website varies slightly from the 5/24/2011 version in that the web-based version provides all the disease information in one scrollable window.

For cases diagnosed 2010-2011, access the 2010 Hematopoietic Database at http://seer.cancer.gov/tools/heme/. Click on Hematopoietic Project. Click on Hematopoietic and Lymphoid Database. For 2010-2011 diagnoses, click on the "use the 2010 database" label in the upper right corner of the screen. The 2010 Hematopoietic Coding Manual (PDF) button will appear to indicate the correct version of the program is available now for query.

History

Last Updated
07/02/2012

Date Finalized